0.014428 0.000000 0.000000 0.000000 0.043122 0.000000 0.000000 0.000000 0.034200 0.00000 0.00000 0.00000 TWO ALTERNATE CONFORMATIONS ARE GIVEN FOR THE SIDE CHAIN OF GLU 7. Danishefsky, A.T. Wlodawer, A. Kim, K.-S. Tao, F. Woodward, C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 69.310 23.190 29.240 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Protein Sci. PRCIEI 0795 0961-8368 2 577 587 8518731 Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A. 1993 US Protein Sci. PRCIEI 0795 0961-8368 2 588 Crevice-Forming Mutants of Bovine Pancreatic Trypsin Inhibitor: Stability Changes and New Hydrophobic Surface 1993 UK J.Mol.Biol. JMOBAK 0070 0022-2836 220 757 Crystal Structure of a Y35G Mutant of Bovine Pancreatic Trypsin Inhibitor 1991 UK Protein Eng. PRENE9 0859 0269-2139 3 591 Structural Effects Induced by Removal of a Disulfide-Bridge. The X-Ray Structure of the C30A(Slash)C51A Mutant of Basic Pancreatic Trypsin Inhibitor at 1.6 Angstroms 1990 US Biochemistry BICHAW 0033 0006-2960 29 10018 X-Ray Crystal Structure of the Protease Inhibitor Domain of Alzheimer'S Amyloid Beta-Protein Precursor 1990 UK J.Mol.Biol. JMOBAK 0070 0022-2836 198 469 Structure of Form III Crystals of Bovine Pancreatic Trypsin Inhibitor 1987 UK J.Mol.Biol. JMOBAK 0070 0022-2836 193 145 Comparison of Two Highly Refined Structures of Bovine Pancreatic Trypsin Inhibitor 1987 UK J.Mol.Biol. JMOBAK 0070 0022-2836 180 301 Structure of Bovine Pancreatic Trypsin Inhibitor. Results of Joint Neutron and X-Ray Refinement of Crystal Form II 1984 UK J.Mol.Biol. JMOBAK 0070 0022-2836 167 911 Pancreatic Trypsin Inhibitor. A New Crystal Form and its Analysis 1983 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 6451.472 BOVINE PANCREATIC TRYPSIN INHIBITOR 1 man polymer 18.015 water 56 nat water no no RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNAKSAEDCMRTCGGA RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNAKSAEDCMRTCGGA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos sample 9913 Bos taurus 1.82 32.42 pdbx_database_status software software repository Initial release Version format compliance Version format compliance Data collection Other Refinement description Data collection Refinement description 1 0 1993-10-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2019-07-17 1 4 2019-08-14 _pdbx_database_status.process_site _software.classification _software.classification Y BNL 1992-08-21 REL REL HOH water HOH 70 2 HOH HOH 70 A HOH 102 2 HOH HOH 102 A HOH 110 2 HOH HOH 110 A HOH 111 2 HOH HOH 111 A HOH 112 2 HOH HOH 112 A HOH 113 2 HOH HOH 113 A HOH 117 2 HOH HOH 117 A HOH 119 2 HOH HOH 119 A HOH 122 2 HOH HOH 122 A HOH 126 2 HOH HOH 126 A HOH 127 2 HOH HOH 127 A HOH 129 2 HOH HOH 129 A HOH 133 2 HOH HOH 133 A HOH 134 2 HOH HOH 134 A HOH 138 2 HOH HOH 138 A HOH 140 2 HOH HOH 140 A HOH 143 2 HOH HOH 143 A HOH 145 2 HOH HOH 145 A HOH 156 2 HOH HOH 156 A HOH 157 2 HOH HOH 157 A HOH 158 2 HOH HOH 158 A HOH 160 2 HOH HOH 160 A HOH 203 2 HOH HOH 203 A HOH 205 2 HOH HOH 205 A HOH 214 2 HOH HOH 214 A HOH 218 2 HOH HOH 218 A HOH 220 2 HOH HOH 220 A HOH 223 2 HOH HOH 223 A HOH 302 2 HOH HOH 302 A HOH 311 2 HOH HOH 311 A HOH 312 2 HOH HOH 312 A HOH 313 2 HOH HOH 313 A HOH 314 2 HOH HOH 314 A HOH 317 2 HOH HOH 317 A HOH 319 2 HOH HOH 319 A HOH 400 2 HOH HOH 400 A HOH 401 2 HOH HOH 401 A HOH 402 2 HOH HOH 402 A HOH 403 2 HOH HOH 403 A HOH 404 2 HOH HOH 404 A HOH 405 2 HOH HOH 405 A HOH 406 2 HOH HOH 406 A HOH 407 2 HOH HOH 407 A HOH 408 2 HOH HOH 408 A HOH 409 2 HOH HOH 409 A HOH 410 2 HOH HOH 410 A HOH 411 2 HOH HOH 411 A HOH 412 2 HOH HOH 412 A HOH 413 2 HOH HOH 413 A HOH 414 2 HOH HOH 414 A HOH 415 2 HOH HOH 415 A HOH 416 2 HOH HOH 416 A HOH 417 2 HOH HOH 417 A HOH 418 2 HOH HOH 418 A HOH 419 2 HOH HOH 419 A HOH 420 2 HOH HOH 420 A ARG 1 n 1 ARG 1 A PRO 2 n 2 PRO 2 A ASP 3 n 3 ASP 3 A PHE 4 n 4 PHE 4 A CYS 5 n 5 CYS 5 A LEU 6 n 6 LEU 6 A GLU 7 n 7 GLU 7 A PRO 8 n 8 PRO 8 A PRO 9 n 9 PRO 9 A TYR 10 n 10 TYR 10 A THR 11 n 11 THR 11 A GLY 12 n 12 GLY 12 A PRO 13 n 13 PRO 13 A CYS 14 n 14 CYS 14 A LYS 15 n 15 LYS 15 A ALA 16 n 16 ALA 16 A ARG 17 n 17 ARG 17 A ILE 18 n 18 ILE 18 A ILE 19 n 19 ILE 19 A ARG 20 n 20 ARG 20 A TYR 21 n 21 TYR 21 A PHE 22 n 22 PHE 22 A TYR 23 n 23 TYR 23 A ASN 24 n 24 ASN 24 A ALA 25 n 25 ALA 25 A LYS 26 n 26 LYS 26 A ALA 27 n 27 ALA 27 A GLY 28 n 28 GLY 28 A LEU 29 n 29 LEU 29 A CYS 30 n 30 CYS 30 A GLN 31 n 31 GLN 31 A THR 32 n 32 THR 32 A PHE 33 n 33 PHE 33 A VAL 34 n 34 VAL 34 A TYR 35 n 35 TYR 35 A GLY 36 n 36 GLY 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ARG 39 n 39 ARG 39 A ALA 40 n 40 ALA 40 A LYS 41 n 41 LYS 41 A ARG 42 n 42 ARG 42 A ASN 43 n 43 ASN 43 A ASN 44 n 44 ASN 44 A ALA 45 n 45 ALA 45 A LYS 46 n 46 LYS 46 A SER 47 n 47 SER 47 A ALA 48 n 48 ALA 48 A GLU 49 n 49 GLU 49 A ASP 50 n 50 ASP 50 A CYS 51 n 51 CYS 51 A MET 52 n 52 MET 52 A ARG 53 n 53 ARG 53 A THR 54 n 54 THR 54 A CYS 55 n 55 CYS 55 A GLY 56 n 56 GLY 56 A GLY 57 n 57 GLY 57 A ALA 58 n 58 ALA 58 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O TYR 35 A O TYR 35 A N ILE 18 A N ILE 18 A O TYR 21 A O TYR 21 A N ALA 45 A N ALA 45 1 4.59 0.50 120.30 124.89 A A A NE CZ NH1 ARG ARG ARG 1 1 1 N 1 13.81 2.20 113.40 127.21 A A A CA CB CG GLU GLU GLU 7 7 7 A A N 1 12.85 2.00 118.30 131.15 A A A CG CD OE1 GLU GLU GLU 7 7 7 A A A N 1 -3.96 0.50 120.30 116.34 A A A NE CZ NH2 ARG ARG ARG 17 17 17 N 1 3.21 0.50 120.30 123.51 A A A NE CZ NH1 ARG ARG ARG 39 39 39 N 1 -3.36 0.50 120.30 116.94 A A A NE CZ NH2 ARG ARG ARG 39 39 39 N 1 -4.20 0.50 120.30 116.10 A A A NE CZ NH2 ARG ARG ARG 53 53 53 N DENSITY FOR 2 CARBOXY-TERMINAL RESIDUES (GLY 57, ALA 58) WAS UNCLEAR IN THE FINAL MAPS AND TEMPERATURE FACTORS ARE HIGH FOR THIS REGION. 0.169 0.169 2.0 10.0 3395 1 1.0 2.0 10.0 56 509 0 0 453 0.015 2.399 3.0 3.212 3.5 3.888 4.0 5.596 5.0 model building X-PLOR refinement PROLSQ refinement X-PLOR phasing X-PLOR BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH PHE 45 REPLACED BY ALA (F45A) CREVICE-FORMING MUTANTS IN THE RIGID CORE OF BOVINE PANCREATIC TRYPSIN INHIBITOR: CRYSTAL STRUCTURES OF F22A, Y23A, N43G, AND F45A 1 N N 2 N N A PRO 2 A PRO 2 HELX_P A GLU 7 A GLU 7 5 H1 6 A SER 47 A SER 47 HELX_P A GLY 56 A GLY 56 1 H2 10 disulf 1.982 A CYS 5 A SG CYS 5 1_555 A CYS 55 A SG CYS 55 1_555 disulf 2.063 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 1.982 A CYS 30 A SG CYS 30 1_555 A CYS 51 A SG CYS 51 1_555 SERINE PROTEASE INHIBITOR SERINE PROTEASE INHIBITOR BPT1_BOVIN UNP 1 1 P00974 MKMSRLCLSVALLVLLGTLAASTPGCDTSNQAKAQRPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNF KSAEDCMRTCGGAIGPWENL 36 93 1FAN 1 58 P00974 A 1 1 58 1 PHE CONFLICT ALA 45 1FAN A P00974 UNP 80 45 3 anti-parallel anti-parallel A LEU 29 A LEU 29 A TYR 35 A TYR 35 A ILE 18 A ILE 18 A ASN 24 A ASN 24 A ALA 45 A ALA 45 A ALA 45 A ALA 45 19 P 21 21 21